FDA experts to review safety of Essure birth control implant
WASHINGTON - Federal medical experts will take a closer look at a host of problems reported with the birth control implant called Essure, including chronic pain, bleeding, headaches and allergic reactions.
Essure has been sold for 13 years but the Food and Drug Administration has recently received a flurry of complaints from women implanted with the device, which is marketed as the only permanent birth control method that doesn't require surgery.
Essure consists of two metallic coils inserted into the fallopian tubes, where they spur the growth of scar tissue that eventually blocks sperm.
Studies suggest problems with Essure are relatively rare, but thousands of women have attributed various health problems to the implant.
The agency will ask an expert panel to review the issue Wednesday and recommend possible solutions.
Desktop NewsClick to open Continuous News in a sidebar that updates in real-time.
Massive inferno at Hola Nola Foods facility likely sparked by electrical issue
INVESTIGATIVE UNIT: Employees fear 19 reports filed about broken prison cells fell...
Amazon investing $200M into new facility at former Cortana Mall site
It's back! WBRZ's annual July 4th fireworks show returns this year
Suspended LSU athletics officials used university emails to conduct business while on...